Next Article in Journal
Ins and Outs of Multipartite Positive-Strand RNA Plant Viruses: Packaging versus Systemic Spread
Previous Article in Journal
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
Previous Article in Special Issue
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Article Menu

Export Article

Open AccessEditorial
Viruses 2016, 8(8), 226; doi:10.3390/v8080226

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure

1
Institut de Recherche sur les Maladies Virales et Hépatiques, Inserm, U1110, 3 rue Koeberlé, 67000 Strasbourg, France
2
Université de Strasbourg, 67000 Strasbourg, France
3
Institut Hospitalo-Universitaire, Pôle Hépato-Digestif, Hopitaux Universitaires de Strasbourg, 67000 Strasbourg, France
*
Author to whom correspondence should be addressed.
Academic Editor: Eric O. Freed
Received: 29 July 2016 / Accepted: 9 August 2016 / Published: 16 August 2016
(This article belongs to the Special Issue HCV Drug Resistance)
View Full-Text   |   Download PDF [155 KB, uploaded 16 August 2016]

Abstract

Chronic hepatitis C is a major cause of chronic liver disease, including liver cirrhosis and hepatocellular carcinoma. The development of direct-acting antivirals (DAAs) revolutionized hepatitis C virus (HCV) treatment by offering genuine prospects for the first comprehensive cure of a chronic viral infection in humans. While antiviral resistance is a significant limitation for interferon-based therapies, resistance and treatment failure still appear to be present in a small fraction of patients even in state-of-the-art DAA combination therapies. Therefore, treatment failure and resistance still remain a clinical challenge for the management of patients not responding to DAAs. In this special issue of Viruses on HCV drug resistance, mechanisms of antiviral resistance for different classes of antiviral drugs are described. Furthermore, the detection and monitoring of resistance in clinical practice, the clinical impact of resistance in different patient groups and strategies to prevent and address resistance and treatment failure using complementary antiviral strategies are reviewed. View Full-Text
Keywords: hepatitis C virus; antiviral therapy; antiviral resistance; treatment failure hepatitis C virus; antiviral therapy; antiviral resistance; treatment failure
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Colpitts, C.C.; Baumert, T.F. Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure. Viruses 2016, 8, 226.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top